"Good Publication Practice for Pharmaceutical Companies": where are we now?
Eighteen months on from the publication of "Good Publication Practice for Pharmaceutical Companies," one member of the working group that developed these guidelines reflects on what they have achieved and what has changed since they were first developed.
Wager
Elizabeth
E
liz@sideview.demon.co.uk
D016265:Conflict of Interest; D030881:Disclosure / Q000941:ethics / Q000592:standards / Q000639:trends; D004345:Drug Industry / Q000941:ethics / Q000592:standards* / Q000639:trends*; D017408:Guidelines as Topic; D011643:Publishing / Q000941:ethics / Q000592:standards* / Q000639:trends*; D015871:Scientific Misconduct; D014481:United States